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Amended  proposal  for  a 
CQUNCIL  DIRECJIYE 
relating  to  the medical  devices 
(presented by  the Commission  pursuant  to Article  149(3) 
of  the  EEC-Treaty) 
. •.·.·· -1-
EXPLANATORY  MEMORANDUM 
Following  the  oplnton<n  from  the  European  Pari lament  given  at 
the  first  reading  during  the  session  held  between  11  to 
14  May  1992,  the  Commission  has  decided,  In  accordance  with  the 
terms  of  Article  149  paragraph  3  of  the  EE~  Treaty  ,  to  amend  the 
proposal  for  a  Directive  concerning  medical  devices  COM  (91)  287 
final  - SYN  353(2), 
The  Commission  has  accepted: 
a  significant  number  of  amendments  Improving  the  proposal 
for  a  Directive  by  the  provision  of  more  Information,  In 
particular  In  respect  of  the  field  of  application,  In  the 
definitions  and  certain essential  requirements, 
an  addition  In  Article  15  on  clinical  Investigations 
strengthening  the  Importance  of  opinions  expressed  by  the 
ethics  committee  concerned, 
a  new  article  (17  (a))  providing  for  the  adoption  of  a 
Community  register  on  the  Implementation  of  the  directive. 
This  amendment  aimed  to  Improve  transparency  In  the  steps  to 
be  taken  In  the  Implementation  of  the  directive, 
the  extension  of  the  transitional  scheme  for  products  In 
class  I  from  one  year  to  two·  years  In  order  to  allow  the 
parties  concerned  to  adapt  more  easily  to  the  Community 
system. 
The  Commission  did  not  wish  to  take: 
an  amendment  aiming  to  convert  the  regulatory·commlttee 
a  Consultative  Committee.  The  tasks  allocated  to  the 
regulatory  Committee  are  In  the  field  of  public  health 
protection  being  related  to  measures  concerning 
certification  and  the  control  of  c.llnlcal  Investigations 
humans.  Consequently,  the  regulatory  Committee  procedure 
suitable, 
Into 
on 
was 
amendments  proposing  a  formal  consultation  of  manufacturers 
and  of  users  In  the  context  of  the  Committee.  This 
consultation  Is  not  necessary  and  was  not  provided  for  In 
the  decision  87/373/EEC  on  committee  procedures.  However, 
the  Commission  has  always  consulted  the  various  parties 
concerned  during  preparatory  work  and  had  already 
established  a  practice  of  Informal  consultation  In  this 
sector, 
an  amendment  aiming  to  Impose  a  system  for  alI  the  Member 
States  compel I lng  the  users  to  notify  any  Incidents  having 
taken  place  with  devices.  The  Commission  considered  that  by 
following  the  principles  of  subsidiarity,  the .decision  to 
have  such  a  system  needs  to  be  taken  by  each  Member  St~te 
Individually, 
(1)  A3-0178  of  6.05.92 
(2)  OJ  C237  OF  12.9.1991 
.' - -'1  E:L  -
an  amendment  concerning  the  suppression  of  certification  by 
product  qua II ty  assurance  for  products  of  c I ass  I I a.  The 
.propos  a I  ens  u r e s  a  h I g h  and  s u I t a b I e  I eve I  of  p rot e c t I on . 
The  suppression  of  this certification option  was  not 
justified  In  particular  In  view  of  the  difficulties  which 
would  result  as  a  consequence  for  the  medium-sized  size 
unde~taking which  needs  the  flexlbl I lty  of  this  alternative 
route, 
an  amendment  which  aimed  to  suppress  the  obllgat ion  of  the 
manufacturers  to  estab I Ish  a  post-marketIng  surve I I I ance 
system.  The  Incidents  experienced  In  the  past  with  certain 
Implants  (cardiac  valves,  breast  Implants)  showed  that  the 
manufacturers  of  such  sensitive  products  have  to  take  post-
marketing  survel I lance  measures  to  be  able  to  react  quickly, 
when  problems  arl$e  after  marketing,  and  1n  order  to  I lmlt 
the  possibilities  for  repetition  of  similar  problems, 
some  amemdments  covering  changes  of  an  editorial  nature, 
dealing  In  particular  with  only  one  linguistic  version  and 
not  p r o v I d l.n g  any  over a I I  I m  p rove  men t . 
In  summary,  the  Commission  accepted,  entirely  or  partly,  36  of 
the  62  amendments  approved  by  Par I lament. --1 Q,-_ 
Amended  proposal  for  a 
COUNCIL  DIRECTIVE 
relating  to  the  medical  devices On  the  left  side  you  wl  I 1  find  the  Initial  text  of  the  "Whereas",  articles and 
annexes of  the  proposal  for  a  Council  Directive on  medical  devices  COM(91)  287 
final  SYN  353. 
On  the  right  side you  will  find  the modifications  proposed  by  the  Commission. 
Initial  text 
FOURTH  RECITAL 
Whereas  the  harmonized  provisions must 
be  distinguish  from  the measures 
adopted  by  the  Member  States  to manage 
the  funding of  public health  and 
sickness  Insurance  schemes  relating 
directly or  Indirectly  to such  devices; 
whereas,  therefore,  these provisions  do 
not  affect  the ability of  the Member 
States  to  Implement  the  abovementioned 
measures  provided Community  law  Is 
comp I I  ed w  I t h ; 
Modified  text 
FOURTH  RECITAL 
Whereas  the  harmonized  provisions must 
be  distinguish  from  the measures 
adopted  by  the  Member  States  to manage 
the  funding  of  public  health  and 
sickness  Insurance  schemes  relating 
directly or  Indirectly  to such  devices; 
whereas,  therefore,  these  provisions  do 
not  affect  the  ab I I r ty of  the  Member 
States  to  Implement  the  abovementioned 
measures  provided  Community  law  Is 
complied with;  whereas  this means  Inter 
alia that  Member  States may  determine 
which  categories and  types of  device 
are eligible for  reimbursement  under 
such  pub! rc  health  and  sickness 
Insurance  schemes,  but  once  those 
categories and  types of  device  are 
determined,  alI  devices  within  those 
categories or  of  those  types  which 
comply  with  the  provisions of  this 
present  directive  should  In  principle 
be  reimbursable  under  such  pub! lc 
health  and  Insurance  schemes; - 2  -: 
Initial  text 
SIXTH  RECITAL 
Whereas  certain medical  devices  are 
Intended  to administer  med!clryal 
products within  the meaning  of  Council 
~lrectlve 65/65/EEC  of  26  January  1965 
on  the  approximation of  provisions  laid 
down  by  law,  regulation or  · 
admlnlstrat)ve action  relating to 
proprietary medicinal  products,  a~  last 
amended  by  Directive 89/381/EEC; 
whereas,  In  such  cases,  the  placing of 
the medicinal  product  on  the market  Is 
go.ver ned  by  DIrect I  ve  65/65/EEC; 
whereas  a  distinction must  be  drawn 
between  the  above  mentioned  devices  and 
medical  devices  Incorporating,  Inter 
a! Ia,  substances which,  If  used 
separately,  may  be  consJdered  to be  a 
medicinal  substance within  the meaning 
of  Directive 65/65/EEC; 
whereas,  In  such  cases,  If  the 
substances are  Incorporated  In  the 
medical  devices  to  help  them  operate, 
the  placing of  the  devices on  th.e 
market  Is  governed  by  this Directive; 
Mod I fl  e d  text 
SIXTH  RECITAL 
Whereas  certain medical  devices  are 
Intended  to  adm l.n I  ster medIc Ina I 
products within  the  meaning  of  Council 
Directive 65/65/EEC  of  26  January  1965  · 
on  the  approxl~atlon of  provisions  laid 
down  by  law,  regulation or 
administrative  action  relating  to 
proprietary medicinal  products,  as  last 
amended  by  Directive 92/27/EEC  (1}; 
whereas,  In  such  cases,  the  placing of 
the medicinal  product  on  the market  Is 
governed  by  Directive 65/65/EEC  and  the 
placing of  the  device on  the market  by 
this present  Directive~ 
whereas  a  distinction must  be  drawn 
between  the  above  mentioned  devices  and 
medical  devices  Incorporating 
substances which,  whl  le  not  designed  to 
be  administered  as  a  medicinal  product, 
are bloavallable with  the meaning  of 
this Dlrect.tve  and  If  used  separately, 
may  be  considered  to  be  a  medicinal 
substance within  the meaning  of 
Dlr~ctlve 65/65/EEC; 
whereas,  In  such  cases,  If  such 
substances are  Incorporated  In  a 
medical  device  to  Improve  Its safety, 
quality or  performance,  the  placing of 
such  devices on  the market  Is  governed 
by  this present  Directive; 
(1)  OJ  L 113  of  30  Apr!  1  1992,  page  8. lnltl.al  text 
6TH  RECITAL  (follow) 
Whereas,  In  this context,  In  the  event 
of  the bloavallablllty of  such 
substances,  the safety,  Qual lty and 
usefulness of  the substances must  be 
verified by  analogy with  the 
appropriate methods  speclfl~d  In 
Council  Directive 75/318/EEC  of  20  May 
1975  on  the  approximation of  the  laws 
of  the  Member  States  relating  to 
analytical,  pharmaco-toxlcologlcal  and 
clinical  standards and  protocols  In 
respect  of  the  testing of  proprietary 
medicinal  products,  as  last  amended  by 
Directive 89/341/EEC; · 
TWENTY-SECOND  RECITAL 
Whereas  the  application of  some 
provisions of  this Directive must  be 
facilitated by  means  of guidelines 
published by  the Commission; 
- 3  -
Modified  text 
6TH  RECITAL  (follow) 
Whereas,  In  this context,  In  the  event 
of the  bloavallabl llty of  such 
substances,  the safety,  Qual lty and 
··usefulness of  the  substances must  be 
verified by  means  of  control  systems 
which  may  be  analogous  to  the 
appropriate methods  specified  In 
council  Directive 75/318/EEC  of  20  May 
1975  on  the  approximation of  the  laws 
of  the  Member  States  relating  to 
analytical,  pharmaco-toxlcologlcal  and 
611nlcal  standards  and  protocols  In 
respect  of  the  testlng.of proprietary 
medicinal  products,  as  last  amended  by 
Directive 91/507/EEC; 
RECITAL  7a  (new) 
Whereas  the  "essential  reQuirements" 
and  reQuirements  set out  In  the  Annexes 
to  this Directive,  Including  any 
reference  to  "minimising"  or  "reducing" 
risk must  likewise  be  Interpreted and 
applied  In  such  a  way  as  to  take 
account  of  technology  and  practice 
existing at  the  time  of  design  and  of 
technlcal,and economical 
considerations,  bearing  In  mind  the 
relationship between  risk  and  cost  and 
what  may  reasonably  be  expected  In  al1 
circumstances  by  Intended  users of 
1T1ed I  ca I  devIces. 
TWENTY-SECOND  RECITAL 
Whereas  the  appl !cation of  some 
provisions of  this Directive must  be 
facilitated by  means  of  guide! lnes 
published  by  the  Commission;  and  by 
making  available  resources enabling  the 
Commission  successfully  to carry out 
Information  programmes at  national 
I  eve I; - 4  -
In It I  a I 'text 
ARTICLE  1 
1.  This  Directive shall  apply  to 
medical  devices.  It  also covers  the 
accessories  to which  the provisions  for 
medical  devices apply. 
2.  For  the  purposes of  this Directive, 
the  following  definitions shall  apply  ; 
a)  medical  device  (hereinafter  referred 
to as  "devIces''>  means  any  Instrument, 
apparatus,  appll~nce. material  or other 
article,  Including software.  whether 
used  ~lone or  ln  combination,  Intended 
by  the manufacturer  to be  used  for 
human  beings  solely or  principally  for 
the  purpose .of  : 
-diagnosis.  prevention.  monitoring. 
treatment  or  alleviation of  disease. 
Injury or  handicap. 
~  Investigation,  replacement  or 
modification of  the anatomy  or  of  a 
physiological  process. 
-control  of  conception. 
and  which  does  not  achieve  Its 
principal  Intended  action  In  or  on  the 
human  body  by  pharmacological. 
Immunological  or  metabolic means.  but 
which  may  be  assisted  In  Its function 
by  such  means, 
b)  "accessory"  means  an  article which. 
while  not  a  device,  Is  required. 
according  to  the  Intended  purpose 
attributed to  It  by  the manufacturer, 
to enable  the  device  to be  used  as 
specified• 
Mod l.f led  text 
ARTICLE  1 
1.  This Directive  shal I  apply  to 
medical  devices.  It  also covers  the 
accessories .to which  the provisions  for 
medical  devices  apply.  partlcu)arly  the 
, provisions governing  the  class to which 
these  acc~ssorle~ belong. 
~.  unchanged 
a)  unchanged 
-diagnosis.  prevention,  monitoring, 
treatment  or  alleviation of  disease, 
-diagnosis,  monitoring,  treatment or 
alleviation of  Injury or  handicap, 
- unchanged 
:- unchanged 
unchanged 
b)  "accessory"  means  an  article which, 
while  not  being  a  device.  Is  Intended 
specifically by  Its manufacturer· to be 
~sed together with  a  device  to enable 
It  to be  used  In  accordance  with  the 
manufacturer's  Intentions, - 5  -
Initial -text 
ARTICLE  1  (2) 
(g)  "manufacturer" means  the  natura~ or 
legal  person with overall 
responsibility  for  the design, 
manufacturer,  packaging  and  labelltng 
of  a.devlce before  It  Is  placed on  the 
market  on  his own  behalf,  regardless of 
whether  these.operatlons are carried 
out  by  that  person  himself  or  on  his 
behalf  by  a  third party. 
The  natural or  legal  person who 
assembles,  packages,  processes  and/or 
labels one  or more  ready-made  products 
and/or  assigns  them  to their  Intended 
purpose  as a  device with  a  view  to 
their  being placed on  the market  on  his 
own  behalf  Is  also considered  to be  a 
manufacturer.  This sub-paragraph  does 
not  app I  y  to  the  person,  who,  wh  I' I  e  not 
a  manufacturer  within  the meaning  of 
the  first  sub-paragraph  assembles  or 
adapts devices already on  the market  to 
their  Intended  purpose  for  an 
Individual  patient. 
ARTICLE  1  (3) 
3.  Where  a  device  Is  Intended  to 
administer  a  substance defined  as  a 
medicinal  product within  the meaning  of 
Article  1 of Directive 65/65/EEC~ that 
substance shall·be subject  to  the 
marketing  authorization system  provided 
for  In  that  Directive. 
Modified  text 
ARTICLE  1  (2) 
(g)  "manufacturer"  means  the  natural  or 
legal  person with  responslbll lty  for 
the design,  manu~acturer, packaging  and 
labelling of  a  device  before  It  Is 
placed on  the market  on  his own  behalf, 
regardless of whether  these operations 
are carried out  by  that  person  himself 
or  on  his behalf  by  a  third party. 
The  obligations  Imposed  on 
manufacturers  under  the  terms of  this 
Directive shal I  also apply  to  the 
natural  or  legal  person  who  assembles. 
packages,  processes  and/or  labels one 
or  more  ready-made  products  and/or 
assigns  them  to  their  Intended  purpose 
as a  device with  a  view  to  their  being 
placed on  the market  on  his own  behalf. 
This sub-paragraph  does  not  apply  to 
the  person,  who,  whl  le  not  a 
manufacturer  within  the meaning  of  the 
first  sub-paragraph  assembles  or  adapts 
devices already on  the market  to  their 
Intended  purpose  for  an  Individual 
patient. 
ARTICLE  1  ( s} 
~.  Where  a  device  Is  Intended  to 
administer  a  substance defined  as  a 
medicinal  product  within  the meaning  of 
Article  1 of  Directive 65/65/EEC,  that 
substance shall  be  subject  to  the 
marketing  authorization system  provided 
for  In  that  Directive. 
If  such  a  device  Is  placed on  the 
market  or  put  Into service  by  the 
manufacturer  separately  from  the 
medicinal  product,  It  shall  be  governed 
by  this present  Directive. 
If,  on  the other  hand,  such  a  device  Is 
placed on  the market  by  the 
manufacturer  In  such  a  way  that  the 
device  and  the medicinal  product  form  a 
single unit,  the  combined  product  shall 
be  governed  by  Directive 65/65/EEC  and 
this present  Directive  respectively. - 6  -
Initial .text  Modified  text 
ARTICLE  1 
5a  (new) 
This  Directive  does  not  apply  to 
personal  protective eQuipment  covered 
by  Directive 89/686/EEC.  The  assessment 
of whether  a  product  fa I Is  under  the , 
aforesaid Directive or  under  this 
Directive shall  In  particular  take 
account  of  the principal  Intended 
purpose  of  the  product  and  where  and 
how  It  Is  to  be  used. 
ARTICLE  10  ARTICLE  10 
1.  Member  States shal I  take  the  1.  unchanged 
necessary steps  to ensure  that  any 
Information  brought ·to their  knowledge, 
In  accordance  with  the  provisions of 
this Directive,  regarding  the  Incidents 
mentioned  b•low  Involving  a  class  I Ia, 
Jib or  I I I  device  Is  recorded  and 
evaluated  In  a  central !zed  manner 
a)  any  deterioration  In  the 
characteristics and/or  performance of  a 
device,  as  wei~ as  any  Inaccuracies  In 
the  labelling or  the  Instruction 
leaflet which  might  lead  to or might 
have  Jed  to  the  death of  a  patient or 
user  or  to a  serious deterioration  In 
his state of  health; 
b)  any  technical  or  medical  reason 
connected with  the  device  leading  to 
systematic  recall  of  devices of  the 
same  type  by  the manufacturer. 
a)  any  malfunction of  or  deterioration 
In  the characteristics and/or 
performance  of  a  device  as  specified  by 
the manufacturer,  as  wet  1  as  any 
Inaccuracies  In  the  label ling  or  the 
Instruction  leaflet  which  might  lead  to 
or  might  have  led  to  the  death  of  a 
patient  or  ~ser or  to a  serious 
deterioration  In  his state of  health; 
b)  any  technical  or  medical  reason  to 
do  with  the characteristics or 
performance  of  a  device  leading,  for 
the  reasons  referred  to  In  subparagraph· 
(a)  above,  to.systematlc  recal I of 
devices of  the  same  type  by  the 
manufacturer. - 7  -
In! t Ia!  ·text 
ARTICLE  11 
9.  Decisions  taken  by  the notified 
bodies  In  accordance with  Annexes  II 
and  Ill  shall  be  valid for  a  maximum  of 
five  years and  may  be  extended on 
appl !cation for  further  periods of  five 
years. 
ARTICLE  12 
1.  Any  natural  or  legal  person who 
assembles devices bearing  the  EC  mark 
for  their  Intended  purpose  and  within 
the  limits of use specified by  the 
manufacturers with  regard  to their 
compatibility with other  devices  In 
order  to put  them  on  the market  In  the 
form  of a  system,  kit or operation pack 
shall  draw  up  a  declaration  In  which  he 
states that  : 
a)  he  has  verified  the mutual 
compatibility of  the devices which  make 
up  the system,  kit or operation pack  In 
accordance with  the manufacturers• 
Instructions and  that  assembly  has  been 
carried out  In  accordance  with  these 
Instructions; 
b)  the system,  kit or operation pack 
has,  where  applicable,  been  packaged  In 
accordance with  the manufacturers· 
Instructions or  the  limits applicable 
to  the various devices; 
Modified  text 
ARTICLE  11 
9.  Decisions  taken  by  the notified 
bodies  In  accordance with Annexes  II 
and  Ill  shal I  be  valid for  a  maximum  of 
five  years  and  may  be  extended on 
application  for  further  periods of  five 
years.  These  decisions must  be  conveyed 
In'  good  time. 
ARTICLE  12 
1.  Any  nafural  or  legal  person who 
assembles devices  bearing  the  EC  mark 
for  their  Intended  purpose and  within 
the  limits of  use specified by  the 
manufacturers with  regard  to their 
compatibility with other  devices  In_ 
order  to put  them  on  the market  In  the 
form  of or  as  part of  a  system,  kit or 
procedure pack  with,  when  appropriate, 
any  other  compatible product  shall 
Inform  the competent  authority  In 
accordance with  the provisions of 
Article 14  that  he  Is  engaged  In  such 
an  activity  In  general  and  shall  draw 
up  a  declaration  In  which  he  states 
that  : 
a)  he  has verified the mutual 
compatibility of  the  devices and  any 
other  products which  make  up  the 
·.system,  kIt or  procedure pack  In 
accordance with any  Instructions  from 
the manufacturers  and  that  assembly  has 
been  carried out  In  accordance  with 
these  Instructions; 
b)  the system,  kit or  procedure pack 
has,  where  applicable,  been  packaged  In 
accordance with  any  relevant 
Instructions from  the manufacturers or 
the  limits applicable to the various 
devices or  other  products as  the case 
may  be; ~s-
I n I t  I a I  t@Xt 
ARTICLE  14 
1.  An)'  manufacturer  who.  on  his  own 
behalf.  gJaces  devices on  the market  In 
accordance with  the procedures referred 
to  In  Article  11(4)  and  (5)  shall 
Inform  tne competent  authorities of  the 
Member  state  In  which  he  has  his 
registered  place  of  business  of  the 
address  of  the  registered  Pl~ee  of 
bus 1  ness  and  the  category  of  devIces 
concerned. 
ARTICLE  15 
1.  In  tne  case  of  devices  falling 
within classes  1.  lla and  lib which  are 
Intended  for  clinical  investigations. 
the  manufacturer •. or  his  authorl~ed 
representat 1  ve  estab  1  1  sned  1  n  the 
community,  shall  follow  the  procedure 
referred  to  In  Annex  VIII  and  keep  the 
statement  concerned  at  the  disposal  of 
the  competent  authorities. 
2.  In  the  case  of  devices  falling 
within.  olass  Ill  and  Implantable 
devices falling within class  lla or  lib 
Intended  for  clinical  Investigations, 
the  manufacturer,  or  his  authorized 
representative  established  In  the 
community.  snan·  follow  the  procedure 
referred to  In  Annex  VIII  and.  at  least 
45  days  before  the  commencement  of the 
Investigations.  submit  the  statement 
referred to  In  tne abOvementioned  Annex 
to  the  competent  authorities  of  the 
Member  State  In  which  the 
Investigations are to be  conducted.  . 
The  manufacturer  may .  commence  the 
relevant clinical  Investigations at the 
end  of  a  period  of  45  day$  after 
notification.  unless  the  competent 
authorities  nave  notified  him  within 
that  period  of  a  decision  to  the 
contrary  based  on  considerations  of 
public  health  Or"  p~llc  order. 
Modified text 
ARTICLE  14 
1.  Any  manufacturer  who,  on  his own 
behalf, places devices on the market In 
accordancewiththegroceduresreferred 
to  In  Article  11(4) ·and  (5)  shall 
Inform the competent authorItIes of the 
Member  State  in  which  he  has  his 
registered  place  of  business of  the 
address  of  the  registered  glace  of· 
business  and  the  designation  o1  the 
devices. concerned. 
ARTICLE  15 
1 •  In  the  ease  of  dev i cas  fa 1  1  1  ng 
within classes 1.  I Ia and lib which are 
Intended for clinical  Investigations 
duly  Justlf.Jed In  accordance with the 
provisions of Annex  Vlll,  point 2.2, 
the  manufacturer.  or  his  authorized 
representative  established  In  the 
Community?  shal I  follow the procedure 
referred to In Annex  VI I I and keep the 
statement concerned at the dlsposa 1 of 
the competent  authorities. 
2.  In  the  case  C?f  devices  fall Jng 
within  clase  Ill  and  implantable 
devices fal i Jngwlthln class 1  Ja or I Ib 
which  are  Intended  for  clinical 
Investigations  duly  ju!itlfJed  Jn 
accordance w  J th thlil prov 1  s 1  ons af Annex 
VIII. point 2.2. the manufacturer, or 
his  authorized  representative 
&stab I l_shed  In  the  Commun 1 ty,  sha  J 1 
follow  the  procedure  referred  to  In 
Annex VIII and, at least 45 days before 
thecommencementofthelnve~tigatlons, 
. submit the statement referred to ln the 
abovementioned Annex  to the competent 
autnorltle$  Of  tne  Member  State  fn 
wn I eh  t.he  Invest I  gat fons  are  to  be 
conducted. 
unchanged - 9  -
Initial  text 
ARTICLE  15  (following) 
ARTICLE  17 
2.  The  EC  mark  of  conformity,  as shown 
In  Annex  XII,  must  appear  In  a  visible, 
legible  ~nd  Indelible  form  on  the 
device,  where  practicable and 
appropriate,  and/or  on  the sales 
packaging  and  the  Instruction  leaflet. 
It  shall  be  accompanied  by  the 
Identification number  of  the notified 
body  responsible  for  Implementation of 
the  procedures set out  In  Annexes  II, 
IV,  V and  VI  and  the  last  two  digits of 
the  year  In  which  the mark  was  affixed. 
Modified  text 
ARTICLE  15  (following) 
Without  prejudice  to  the  power  of  the 
competent  authorities  to  take  the  final 
decision,  there  Is  generally  no  reason 
for  them  to  Intervene on  the  basis of 
the  previous subparagraph  In  sofar  as 
the ethics committee  concerned  has 
Issued  a  favourable  opinion of  the 
programme  of  Investigations  In 
QUestion,  referred  to  In  Annex  X. 
ARTICLE  17 
2.  unchanged 
It  shal I  be  accompanied  by  the 
Identification number  of  the  notified 
body  responsible  for  Implementation  of 
the  procedures  set out  In  Annexes  II, 
IV,  V and  VI. 
ARTICLE  17a  (new) 
The  Commission  shal I  take  the  necessary 
steps  to create and  ensure  the 
operation of  a  Community  register 
containing  the  necessary  Information 
for  consistent  Implementation of  this 
Directive. - 10  -
Initial  text 
ARTICLE  19 
2.  In  the  event  of  a  decision  to 
withdraw devices  from  the market,  the 
manufacturer,  or  his authorized 
representative established  In  the 
Com~unlty, shall  have  an  opportunity  to 
put  forward  his  viewpoint  In  advance, 
unless  such  consultation  Is  not 
possible  because of  the  urgency  of  the 
measure  to  be  taken. 
ARTICLE  22 
3.  The  following  paragraph· 6  i's  added 
to Article  1  of  Directive 90/385/EEC  : 
"6.  The  following  provisions of  Councl I 
Directive  ...  / ...  /EEC  [on  medical 
devices]  also apply  to active 
Implantable medical  devices  :  Article 
1(2)  g)  and  !); Article  11(6),  (8)  and 
(9):  Article  13(1)(c)  coupled  with 
Article 7;  Article 17(3);  Article 
19(2);  Article  21  points  (a)  and  (c)  of 
the  first  paragraph". 
Modified  text 
ARTICLE  19 
2.  In  the  event  of  a  decision  referred 
to  In  paragraph  1,  the manufacturer,  or 
his authorized  representative 
established  In  the  Community,  shal I 
have  an  opportunity  to put  forward  his 
viewpoint  Ln  advance,  unless  such 
consultation  Is  not  possible  because of 
the  urgency  of  the  measure  to  be  taken. 
ARTICLE  22 
3.  The  definition  In  Article 1(2)(a) of 
Council  Directive  90/385/EEC  shal I  be 
replaced  by  the  definition  In  Article 
1(2)(a) of  this  present  Directive; 
Following  paragraph  6  Is  added  to 
Article  1  of  Directive 90/385/EEC 
"6.  The  following  provisions of  councl 1 
Directive  ...  / ...  /EEC  [on medical 
devices]  also apply  to active 
Implantable  medical  devices  :  Article 
1(2)  b),  g)  and  I);  Article  11(6),  (8) 
and  (9);  Article  13(1)(c)  coupled  with 
Article 7;  Article  17(3);  Article 
19(2):  Article  21  points  (a)  and  (c)  of 
the first  paragraph" - 11  -
Initial  text 
ARTICLE  23 
4.  In  the  case of  devices  which,  for 
the  purposes of  this Directive,  must  be 
the  subject  of  one of  the  procedures 
referred  to  In  Annexes  I I  to VI,  Member 
States shal 1 accept  the  placing on  the 
market  and  putting  Into service of 
devices whlch.conform  to  the  rules  In 
force  In  their  territory on  30  June 
1994  during  the period up  to  30  June 
1997.  In  the case of other  devices 
lawfully  placed on  the  market  before 
30  June  1994,  Member  States shal I 
accept  their  being put  Into service 
during  the  period up  to 30  June  1995. 
ANNEX  I  PARAGRAPH  I 
1.  The  devices must  be  designed  and 
manufactured  In  such  a  way  that,  when 
used  under  the  conditions  and  for  the 
purposes  Intended,  they will  not 
compromise  the clinical  condition or 
the safety of  the  patients,  users  and, 
where  appt !cable, other  persons.  The 
risks associated with  the devices must 
be  reduced  to an  acceptable  level 
compatible with  a  high  !~vel  of 
protection of  health  and  safety. 
ANNEX  I  PARAGRAPH  I 
5.  The  devices must  be  designed, 
manufactured  and  packed  In  such  a  way 
that  their  characteristics and 
performances  during  their  Intended  use 
are  not  adversely affected  In  the 
storage  and  transport  conditions 
(temperature,  humidity,  etc)  laid  down 
by  the manufacturer. 
Modified  text 
ARTICLE  23 
4.  In  the  case of  devices which,  for 
the  purposes of  this Directive,  must  be 
the  subject  of  one  of  the  procedures 
referred  to  In  Annexes  I I  to VI,  Member 
States shal I  accept  the  placing on  the 
market  and  putting  Into service of 
de~lces which  conform  t~ the  rules  In 
force  In  their  territory on  30  June 
1994  during  the  period  up  to  30  June 
1997.  In  the  case of  other  devices 
lawfully  placed on  the market  before 
30  June  1994,  Member  States shall 
accept  their  being  put  Into service 
during  the  period up  to  30  June  1996. 
ANNEX  I  PARAGRAPH  I 
1.  The  devices must  be  designed  and 
manufactured  In  such  a  way  that,  when 
used  under  the  conditions  and  for  the 
purposes  Intended,  they  wl  I I  not 
compromise  the cl lnlcal  condition or 
the safety of  the patients,  users  and, 
where  appllcab.le,  other  persons,  when 
used  under  the  cond 1 t Ions  and  for  the . 
purposes  Intended  provided  that  any 
risks which  may  be  associated with 
their  use constitute acceptable  risks 
when  weighed  against  the  benefits  to 
the patient  and  are  compatible with  a 
high  level  of  protection of  health  and 
safety. 
ANNEX  I  PARAGRAPH  I 
5.  The  devices must  be  designed, 
manufactured  and  packed  In  such  a  way 
that  their  characteristics and 
performances  during  their  Intended  use 
will  not  be·  adverse I  y  affected  In  the 
transport  and  storage  taking  account  of 
the  Instructions  and  Information 
provided  by  the manufacturer. - 12  -
Initial .text 
ANNEX  I  PARAGRAPH  I I 
7.5 The  devlc~s must  be  designed  and 
manufaCtured  In  such  a  way  as  to 
minimize  the  health  risks posed  by 
substances  leaking  from  the  device 
during  use. 
ANNEX  I  PARAGRAPH  II 
8.3 Sterile devices must  be  designed, 
manufactured  and  packed  In  a  non-
reusable  pack  and/or  according  to 
appropriate  procedures  to ensure  that 
they  are sterile when  placed on  the 
market  and  remain  sterile,  under'the 
storage and  transport .conditions  laid 
down,  until  the  protective packaging  Is 
damaged  or  opened. 
ANNEX  I  PARAGRAPH  II 
11.5  Instruments,  apparatus or 
appl lances emitting  radiation must  be 
fitted with  visual  displays  and/or 
audible warnings of  radiation 
emissions. 
ANNEX  I  PARAGRAPH  II 
12.1  Devices  depending  on  software must 
be  designed  In  such  a  way  as  to 
minimize  the  risks arising  from  errors 
In  the  programms. 
Modified  text 
ANNEX  I  PARAGRAPH  II 
7.5 The  devices must  be  designed  and 
manufactured  In  such  a  way  as  to 
minimize  risks  posed  by  substances 
leaking  from  the  device  during  use. 
ANNEX  I  PARAGRAPH  II 
8.3 Sterl le  devices must  be  designed, 
manufactured  and  packed  In  a  non-
reusable  pack  and/or  according  to· 
appropriate  procedures  to ensure  that 
they  are sterile when  placed on  the 
market  and  remain  sterl le,  under  normal 
storage  and  transport  conditions as 
described  In  the  Instructions  and 
Information  suppl led  by  the 
manufactured,  untl I  the  protective 
packaging  Is  damaged  or  opened. 
ANNEX  I  PARAGRAPH  II 
11.5  Devices  Intended  to emit 
Invisible,  potentially  hazardous 
radiation must  be  fitted with  visual 
displays  and/or  audible warnings  of 
radiation emissions. 
ANNEX  I  PARAGRAPH  II 
12.1  Devices  Incorporating  programmable 
electronic systems  must  be  designed  In 
such  a  way  as  to avoid  so  far  as 
reasonably  practicable  risks arising 
from  random  and/or  systematic  fal lures. - 13  -
In It I  a I -text 
ANNEX  I  PARAGRAPH  II 
12.7.5.  Accessible parts of  the  devices 
and  their  surroundings must  not  attain 
potentially dangerous  temperatures 
under  normal  use. 
ANNEX  I  PARAGRAPH  II 
12.8.2 Devices must  be  fitted with  an 
Interlock  and/or  alarm  system  to 
prevent  and/or  Indicate any 
Inadequacies  In  the  flow  rate which 
could  pose  a  danger. 
ANNEX  I  PARAGRAPH  II 
12.9 The  function  of  the  controls and 
visual  displays must  be  clearly 
specified on  the devices. 
ANNEX  I  PARAGRAPH  II 
13.3 The  label  must  bear  the  following 
particulars 
a)  the  name  or  trade  name  and  address 
of  the manufacturer; 
b)  the details strictly necessary  for 
the user  to  Identify  the  device  and  the 
contents of  the  packaging; 
c)  where  appropriate,  the word 
"STERILE"; 
d)  where  appropriate,  the  batch code, 
preceded  by  the word  "LOT",  or  the 
serial  number; 
Modified  text 
ANNEX  I  PARAGRAPH  II 
12.7.5.  Accessible  parts of  the  devices 
(excluding  any  parts or  areas  Intended 
to supply  heat  or  attain a  high 
temperature)  and  their  surroundings 
must  not  attain potentially dangerous 
temperatures under  normal  use. 
ANNEX  I  PARAGRAPH  II 
12.8.2 Devices  must  be  fitted with 
means  to prevent  and/or  Indicate  any 
Inadequacies  In  the  commanded  output 
which  could  pose  a  danger. 
ANNEX  I  PARAGRAPH  II 
12.9 The  function  of  the  controls and 
Indicators must  be  clearly specified on 
the devices. 
ANNEX  I  PARAGRAPH  II 
13.3 unchanged 
a)  unchanged 
b)  unchanged 
c)  where  appropriate,  the  symbol 
!sTERILE'; 
d)  where  appropriate,  the  batch  code, 
preceded  by  the  symbol  ILoTj,  or  the 
serial  number; - 14  -
Initial  ,text 
ANNEX  I  PARAGRAPH  II 
ANNEX  II 
2.  The  declaration of  conformity  Is  the 
procedure whereby  the manufacturer  who 
fulfl Is  the obi lgatlons  Imposed  by 
Section  1 ensures  and  declares  that  the 
products  concerned  meet  the  provisions 
of  this Directive which  apply  to  them. 
The  manufacturer  shall  affix  the  EC 
mark  In  accordance  with  Article  17  and 
shal 1  draw  up  a  written declaration of 
conformity.  This  declaration of 
conformity  shal 1  cover  a  given  number 
of  Identified specimens  of  the  products 
manufactured  and  shall  be  kept  by  the 
manufacturer.  The  EC  mark  shal I  be 
accompanied  by  the  Identification 
number  of  the notified body  which 
performs  the  tasks  referred  to  In  this 
Annex. 
3.  Qual lty  system 
3.1  The  manufacturer  shal I  lodge  an 
appl !cation  for  assessment  of  his 
qual tty  system  with  a  notify  body. 
The  application shal I  Include 
- the  name  and  address of  the 
manufacturer, 
- al 1  the  relevant  Information on  the 
product  or  product  category  covered  by 
the  procedure, 
-a written declaration  that  no 
appl !cation has  been  lodged  with  any 
other  notified body  for  the  same 
products; 
Modified  text 
ANNEX  I  PARAGRAPH  II 
13.6a  (new) 
The  Instructions  for  use  shal I  contain 
an  expl lclt  request  to  the  user  or 
patient  to  Inform  his/her  doctor  or 
medical  Institution of  any  side-effect 
not  referred  to  In  the  Instructions  for 
use. 
ANNEX  II 
2.  unchanged 
The  manufacturer  shall  affix  the  EC 
mark  In  accordance  with  Article  17  and 
shall  draw  up  a  written  declaration of 
conformity.  This  declaration of 
conformity  shal I  cover  a  given  number 
of  products manufactured  on  the  basis 
of  the  approval  of  the  qual tty  system 
and  shal I  be  kept  by  the  manufacturer. 
3.  Qual lty system 
3.1  unchanged 
- unchanged 
- unchanged 
-a written declaration  that  no  such 
application  has  been  lodged  with  any 
other  notified  body  for  the  same 
products; - 15  -
!nltla.!  text 
ANNEX  V 
2.  The  declaration of  conformity  Is  the 
part ~f the  procedure wher$by  the 
manufacturer  who  fulfl Is  the 
obi lgatlons  Imposed  by  Section 1 
ensures  and  declares  that  the  products 
concerned  conform  to  the  type  described 
In  the  EC  type-examination certificate 
and  meet  the  provisions of  this 
Directive which  apply  to  them. 
The  manufacturer  shall  affix  the  EC 
mark  In  accordance with Article 17  and 
shall  draw  up  a  written declaration of 
conformity.  This  declaration of 
conformity shall  cover  a  given  number 
of  Identified specimens of  the ·products 
manufactured  and  shal I  be  kept  by  the 
manufacturer.  The  EC  mark  shal I  be 
accompanied  by  the  Identification 
number  of  the notified body  which 
performs  the  tasks  referred  to  In  this 
Annex. 
3.  Quality  system 
3.1  The  manufacturer  shal I  lodge  an 
appl !cation  for  assessment  of  his 
quality system with  a  notify body. 
The  application shal I  Include 
- the  name  and  address of  the 
manufacturer, 
-all the  relevant  Information on  the 
product  or  product  category  covered  by 
the  procedure, 
-a written declaration  that  no 
application has  been  lodged  with  any 
other  notified body  for  the  same 
products; 
Modified  text 
ANNEX  V 
2.  unchanged 
The  manufacturer  shal I  affix  the  EC 
mark  In  accGrdance  with  Article  17  and 
shall  draw  up  a  written declaration of 
·conformity.  This  declaration of 
conformity  shal 1  cover  a  given  number 
of  products manufactured  on  the  basis 
of  the  approval  of  the  quality  system 
and  shal I  be  kept  by  the manufacturer. 
3.  Qual lty system 
3.1  unchanged 
- unchanged 
- unchanged 
-a written declaration  that  no  such 
application has  been  lodged  with  any 
other notified body  for  the  same 
products; \  .  ,...  16  -
Initial  text 
ANNEX  VI 
2.  The  declaration of  conformity  Is  the 
part  of  the  procedu~e whereby  the 
manufacturer  who~fulf~ls the 
obllgat!ons.lmposed  by  Section  1 
ensur~s and  ~eclares that  the  products 
concerned  conform  to  the  type  described 
In  the  EC  type-examination certificate 
and  meet  the  provisions of  this 
Directive which  apply  ,o.them. 
The  manufacturer  shal I  affix  the  EC 
mark  In  accordance  with Article 17  and 
shal I  draw  up.  a  written declaration of 
conformity.  This declaration or 
conformity  shall  cover  a  given  number 
or  Identified specimens  or  the  products 
manufactured  and  shall  be  kept  by  the 
manufacturer.  The  EC~ mark  sha II  be. 
accompanied  by  the  Identification 
number  or  the notified  body  which 
performs  the  tasks  referred  to  (n  this 
Annex. 
3.  Qual ltv system 
3.1  The  manufacturer  shall  lodge  an 
application  for  assessment  or  h.ls 
qual lty  system with  a  notify body. 
The  app! !cation shall  Include 
- the  name  and  address  or  the 
manufacturer, 
-all the  relevant  Information on  the 
product ·or  product  category  covered  by 
the  procedure, 
-a written declaration  that  no 
application  ~as been  lodged  with  ahy 
other  notified body  for  the  same 
products; 
ANNEX  VIII 
2.2  For  devices  Intended  for  the 
clinical  Investigations covered  by 
Annex  X : 
Modified  text 
ANNEX  VI 
2.  unchanged 
The  manufacturer  shall  affix  the  EC 
mark  In  accordance  with Article 17  and 
shall  draw  up  a  written declaration  of 
conformity.  This  declaration of 
conformity  shall  cover  a  given  number 
of  products manufactured  on  the  basis 
of  the  approval  of  the  qual lty  system 
and  shall  be  kept  by  the  manufactur~r. 
3.  Qual  lty  system 
3.1  unchanged 
- unchanged 
- unch~nged 
-a written  declaration  that  no  such 
application  has  been  lodged  with  any 
other  notified body  for  the  same 
products; 
ANNEX 'VIII 
2.2  unchanged - 17  -
In I  t I  a I ·text 
-data allowing  !dentlflcat,lon of  the 
device  In  Question, 
-an  Investigation  plan stating  In 
particular  the  purpose,  scope  and 
number  of devices  concerned, 
- the oplnlon.of  the ethics committee 
conce~ned and  details of  the  aspects 
covered  by  Its opinion, 
~the name  of  the medical  specialist or 
other  authorized  person  and  of  the 
Institution responsible  for  the 
Investigations, 
-the place,  starting date  and 
scheduled  duration  for  the 
Investigations, 
- a  statement  that  the  device  In 
Question  conforms  to  the essential 
reQuirements  apart  from  the  asp~cts 
covered  by  the  Investigations and  that, 
with  regard  to  those aspects,  every 
precaution  has  been  taken  to protect 
the  health  and  safety of  the patient. 
ANNEX  IX  PARAGRAPH 
2.4 Rule  8 
AI  I  Implantable device  and  long-term 
surgically  Invasive  devices are  In 
class  I lb  unles~ they are  Intended  : 
- to  be  placed  In  the  teeth,  In  which 
case  they  are  In  class  !Ia, 
Modified  text 
,..  unchanged 
-an Investigation plan stating  In 
particular  the  purpose~ scientific, 
technical  or  medical  Justification, 
scope  and  number  of  devices  concerned, 
- unchanged 
- unchanged 
- unchanged 
- unchanged 
ANNEX  IX  PARAGRAPH  I . 
2.4 unchanged 
- to be  placed  In  or  on  the  teeth or 
dental  protheses,  In  which  case  they 
are  In  class  !Ia; 
•  • - 18 .. 
I  o I  t Ia I ·teXt  ~d,  fled tex' 
ANNEX  IX  PARAGR~H  (follow,np)  ~X  IX  PAR~GRAPH I  (fol~owtng) 
- to  be  used  In  direct  contact  wtth  t~e  - ~n~ha~ged 
heart,  the  central  clr~ulatory sy,tem 
or  the  central  nervous  system,  In  ~hlch 
case  they  are  In  cl~ss Ill,  · 
I 
- to undergo  chemic~!  change  in  t~e  ..  unchanged 
bod~,  to  b~ biologically aGtlye,  'o b' 
who!  ly  or mainly  absorb~~.  to  s~ppty 
energy  In  the  form  of  Ionizing 
radiation or  to administer  medl~i~''· 
In  whIch  case  they  are  In  c I  ass  1'1 I • 
. except  If  the  devices  are  ~lac~~ in  the 
teeth. 
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